First results of the double-blind randomized placebo-controlled multicenter clinical trial of DIM-based therapy designed as personalized approach to reverse prostatic intraepithelial neoplasia (PIN)

BACKGROUND: Targeted pharmacological correction is used extensively in medical practice today. 3,3'-Diindolylmethane (DIM) is known as a substance with various anticancer properties. An interim study of the efficacy of a new drug Infemin on the basis of diindolylmethane (DIM) with improved bioa...

Descripción completa

Detalles Bibliográficos
Autores principales: Paltsev, Mikhail, Kiselev, Vsevolod, Drukh, Vadim, Muyzhnek, Ekaterina, Kuznetsov, Igor, Andrianova, Evgeniya, Baranovskiy, Pavel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818865/
https://www.ncbi.nlm.nih.gov/pubmed/27042242
http://dx.doi.org/10.1186/s13167-016-0057-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818865/
https://www.ncbi.nlm.nih.gov/pubmed/27042242
http://dx.doi.org/10.1186/s13167-016-0057-3

Ejemplares similares